The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Affiliation: North Bristol NHS Trust (NBT) Country: United Kingdom |
1. Current Status, Position
Mrs Smith is Principal Pharmacist, Service Development and Governance and Medication Safety Officer (MSO) for North Bristol NHS Trust.
2. Education
Mrs Smith received her BSc (Hons) in Pharmacy from Manchester University (1978) and her MSc in Management Development and Social Responsibility from Bristol University (2001).
She has worked in Hospital Pharmacy for all her career in: Dispensary Management, Clinical Pharmacy, Medicines Information, Management and Governance roles and she is now the Medication Safety Officer for NBT.
She also had a secondment working in Radiology, Pathology and Pharmacy whilst involved in an Operational Service Improvement project.
3. Research Area
Her current speciality is Patient Safety and Service Improvement.
In 2007, NBT was selected to take part in the Institute for Healthcare Improvement / Health Foundation programme of the Safer Patient’s Initiative (SPI2). Their improvement work streams included: “Medicines Reconciliation on Admission” and “Reducing Harm from Anticoagulants”. Subsequent work has included “Reducing the Incidence of Missed Doses”; “Increasing the Use of Patients Own Drugs” and “Improving the provision of a Compliance Aid dispensing service”.
NBT took part in the Southwest Patient Safety Improvement programme “Safer Care South West” and is now working with the West of England Academic Health Science network in safety work involving Insulin and Medicines Reconciliation on Discharge – refer to Community Pharmacy using “PharmOutcomes”.
In 2015 she was nominated and accepted as a Fellow of the Royal Pharmaceutical Society – primarily for her work in improvements in Patient Safety.
Conflict of interest: None
|